BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 25410780)

  • 1. [The relationship and clinicopathological significance of Numb,MDM2 and p53 expression in human pancreatic cancer].
    Sheng W; Dong M; Zhou J; Li X; Liu Q; Dong Q; Li F
    Zhonghua Wai Ke Za Zhi; 2014 Sep; 52(9):675-81. PubMed ID: 25410780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Correlation between Gli1 expression and clinicopathological significance in human pancreatic cancer].
    Sheng WW; Dong M; Zhou JP; Liu QF; Li X; Dong Q
    Zhonghua Wai Ke Za Zhi; 2013 Oct; 51(10):916-21. PubMed ID: 24433772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression and clinical significance of Tspan 1 and Integrin α6 in human pancreatic ductal adenocarcinoma].
    Shi G; Dong M; Sheng W; Zhou J; Yu D; Sun W
    Zhonghua Wai Ke Za Zhi; 2014 Oct; 52(10):781-6. PubMed ID: 25573220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cooperation among Numb, MDM2 and p53 in the development and progression of pancreatic cancer.
    Sheng W; Dong M; Zhou J; Li X; Liu Q; Dong Q; Li F
    Cell Tissue Res; 2013 Nov; 354(2):521-32. PubMed ID: 23881403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinicopathological significance of ISYNA1 expression in pancreatic ductal adenocarcinoma].
    Zhou L; Sheng WW; Shi XY; Zhou JP; Dong M
    Zhonghua Wai Ke Za Zhi; 2019 Mar; 57(3):206-211. PubMed ID: 30861650
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinicopathological significance of the expression of carbonic anhydrase I and II in human pancreatic cancer].
    Sheng WW; Dong M; Zhou JP; Kong FM; Li YJ
    Zhonghua Yi Xue Za Zhi; 2012 Dec; 92(48):3407-11. PubMed ID: 23327700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinicopathological significance and relationship of Gli1, MDM2 and p53 expression in resectable pancreatic cancer.
    Sheng W; Dong M; Zhou J; Li X; Liu Q; Dong Q; Li F
    Histopathology; 2014 Mar; 64(4):523-35. PubMed ID: 24289472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression and significance of leukemia inhibitory factor in human pancreatic cancer].
    Peng F; Zhou J; Sheng W; Zhang D; Dong M
    Zhonghua Yi Xue Za Zhi; 2014 Jan; 94(2):90-5. PubMed ID: 24721346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationship and clinicopathological significance of Numb and epithelial-mesenchymal transition related proteins in human pancreatic cancer].
    Sheng WW; Dong M; Liu ZR; Li YJ; Zhou JP; Dong Q
    Zhonghua Wai Ke Za Zhi; 2016 Dec; 54(12):929-934. PubMed ID: 27916037
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinicopathological significance of the expression of calreticulin in human pancreatic cancer].
    Sheng WW; Dong M; Zhou JP; Li X; Dong Q
    Zhonghua Wai Ke Za Zhi; 2013 Jan; 51(1):58-61. PubMed ID: 23578430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of B cell transposition gene 3 in pancreatic ductal adenocarcinoma and its prognostic value].
    Chen J; Zhou ZC; Liu WB; Wang J; Chen XJ; Shen YY; Zhong ZX
    Zhonghua Wai Ke Za Zhi; 2017 Nov; 55(11):863-867. PubMed ID: 29136736
    [No Abstract]   [Full Text] [Related]  

  • 12. Cooperation of Musashi-2, Numb, MDM2, and P53 in drug resistance and malignant biology of pancreatic cancer.
    Sheng W; Dong M; Chen C; Wang Z; Li Y; Wang K; Li Y; Zhou J
    FASEB J; 2017 Jun; 31(6):2429-2438. PubMed ID: 28223335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ezrin protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas.
    Piao J; Liu S; Xu Y; Wang C; Lin Z; Qin Y; Liu S
    Exp Mol Pathol; 2015 Feb; 98(1):1-6. PubMed ID: 25445504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low RASSF6 expression in pancreatic ductal adenocarcinoma is associated with poor survival.
    Ye HL; Li DD; Lin Q; Zhou Y; Zhou QB; Zeng B; Fu ZQ; Gao WC; Liu YM; Chen RW; Li ZH; Chen RF
    World J Gastroenterol; 2015 Jun; 21(21):6621-30. PubMed ID: 26074700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of TP53 codon 72 and MDM2 SNP 309 polymorphisms in pancreatic ductal adenocarcinoma.
    Hori Y; Miyabe K; Yoshida M; Nakazawa T; Hayashi K; Naitoh I; Shimizu S; Kondo H; Nishi Y; Umemura S; Kato A; Ohara H; Inagaki H; Joh T
    PLoS One; 2015; 10(3):e0118829. PubMed ID: 25734904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative splicing of NUMB, APP and VEGFA as the features of pancreatic ductal carcinoma.
    Zheng KL; He TL; Ji WP; Jiang H; Shen Y; Li G; Zhu SB; Tong BL; Zhang YJ
    Int J Clin Exp Pathol; 2015; 8(6):6181-91. PubMed ID: 26261495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinicopathological significance of the expression of carbonic anhydrase II in human pancreatic invasive ductal cancer].
    Sheng WW; Zhou JP; Kong FM; Li YJ; Dong M
    Zhonghua Wai Ke Za Zhi; 2012 Aug; 50(8):728-31. PubMed ID: 23157907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated transcript levels from the MDM2 P1 promoter and low p53 transcript levels are associated with poor prognosis in human pancreatic ductal adenocarcinoma.
    Grochola LF; Taubert H; Greither T; Bhanot U; Udelnow A; Würl P
    Pancreas; 2011 Mar; 40(2):265-70. PubMed ID: 21404460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sineoculis homeobox homolog 1 protein overexpression as an independent biomarker for pancreatic ductal adenocarcinoma.
    Jin A; Xu Y; Liu S; Jin T; Li Z; Jin H; Lin L; Lin Z
    Exp Mol Pathol; 2014 Feb; 96(1):54-60. PubMed ID: 24263054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression and clinical significance of P53 pathway-associated proteins in pancreatic carcinoma].
    Yu GZ; Zhu MH; Chen Y; Ni CR; Li FM
    Ai Zheng; 2005 Nov; 24(11):1398-403. PubMed ID: 16552971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.